0001179110-16-033386.txt : 20161222
0001179110-16-033386.hdr.sgml : 20161222
20161222170602
ACCESSION NUMBER: 0001179110-16-033386
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161220
FILED AS OF DATE: 20161222
DATE AS OF CHANGE: 20161222
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0000792977
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042742593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 6174983300
MAIL ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MAGNETICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KELLEY BRIAN P
CENTRAL INDEX KEY: 0001269385
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10865
FILM NUMBER: 162067278
4
1
edgar.xml
FORM 4 -
X0306
4
2016-12-20
0
0000792977
AMAG PHARMACEUTICALS INC.
AMAG
0001269385
KELLEY BRIAN P
C/O AMAG PHARMACEUTICALS, INC.
1100 WINTER STREET
WALTHAM
MA
02451
1
0
0
0
Common Stock
2016-12-20
4
A
0
1026
A
1026
D
Stock Option (Right to Buy)
35.50
2016-12-20
4
A
0
6000
A
2026-12-20
Common Stock
6000
6000
D
Stock Option (Right to Buy)
35.50
2016-12-20
4
A
0
2739
A
2026-12-20
Common Stock
2739
2739
D
Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Third Amended & Restated 2007 Equity Incentive Plan, as amended (the "Plan") that will vest in five equal monthly installments commencing on January 1, 2017; however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer.
Not applicable.
Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twenty-four equal monthly installments over two years from the date of grant.
Grant of stock option pursuant to the Plan. This option will vest and become exercisable in five equal monthly installments commencing January 1, 2017.
Nancy R. Smith, attorney-in-fact
2016-12-22